These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29239011)

  • 21. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
    Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
    Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus.
    Krah DL; Provost PJ; Ellis RW
    J Virol Methods; 1995 Jun; 53(2-3):176-87. PubMed ID: 7673386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella-zoster antibody titers in children with leukemia and lymphoma. Relationship of titer to varicella-zoster infection.
    Hutter JJ; Minnich LL; Ray CG
    Am J Dis Child; 1984 Jan; 138(1):56-9. PubMed ID: 6318551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum antibody levels as risk factors in the dissemination of herpes zoster.
    Mazur MH; Whitley RJ; Dolin R
    Arch Intern Med; 1979 Dec; 139(12):1341-5. PubMed ID: 229783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of varicella-herpes zoster immunoglobulin.
    Janot C; Stoltz JF; Avenard G; Perrier P; Schooneman F; Streiff F
    Transfusion; 1981; 21(6):732-4. PubMed ID: 6274067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster].
    Trivello R; Peserico A; Moschen ME; Romano M
    Ann Sclavo; 1977; 19(6):1133-43. PubMed ID: 218503
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinico-pathological studies on herpes zoster; [I]. Changes in antibody titers on herpes zoster].
    Muraki R
    Nihon Hifuka Gakkai Zasshi; 1986 Jan; 96(1):1-7. PubMed ID: 3009931
    [No Abstract]   [Full Text] [Related]  

  • 29. Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies.
    Terada K; Kawano S; Yoshihiro K; Morita T
    Scand J Infect Dis; 1993; 25(6):775-8. PubMed ID: 8052820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell activity in herpes zoster in children without underlying disease.
    Terada K; Kawano S; Yoshihiro K; Morita T
    Scand J Infect Dis; 1993; 25(4):521-4. PubMed ID: 8248754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A relationship between varicella-zoster virus-specific delayed hypersensitivity and varicella-zoster virus-induced anterior uveitis.
    Kezuka T; Sakai J; Minoda H; Takeuchi M; Keino H; Streilein JW; Usui M
    Arch Ophthalmol; 2002 Sep; 120(9):1183-8. PubMed ID: 12215092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody responses to varicella-zoster virus and the role of antibody in host defense.
    Gershon AA; Steinberg SP
    Am J Med Sci; 1981; 282(1):12-7. PubMed ID: 6267940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
    Levy E; Mosovitz B; Friedman M; Sarov I
    Intervirology; 1983; 20(2-3):123-8. PubMed ID: 6313543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed facial nerve weakness after intact canal wall tympanomastoidectomy.
    Basavaraj S; Prakash BG; Shetty TS; Sandhya D; Kallada S
    Otol Neurotol; 2014 Jul; 35(6):1003-6. PubMed ID: 24781104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
    Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
    J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic tests: Varicella-zoster virus].
    Yamashita T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():294-6. PubMed ID: 16111254
    [No Abstract]   [Full Text] [Related]  

  • 37. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.
    Brunell PA; Gershon AA; Uduman SA; Steinberg S
    J Infect Dis; 1975 Jul; 132(1):49-54. PubMed ID: 169308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
    Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
    J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella and herpes zoster: differences in antibody response revealed by the platelet aggregation technique.
    Palosuo T
    Scand J Infect Dis; 1972; 4(2):83-9. PubMed ID: 4341817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.